Homozygous embryos die shortly after stage 16 and do not hatch.
Homozygous germline clones have not been recovered.
akirinKG01343/akirinEP906 embryos show defects in the somatic musculature. 71.4% of embryos have missing muscles, 68.5% have muscle attachment defects and 25.7% have duplicated muscles. 67% of embryos have muscle defects in at least 2 hemisegments.
akirin5/akirinEP906 embryos show defects in the somatic musculature. 35% of embryos have missing muscles, 35% have muscle attachment defects and 6% have duplicated muscles. 44.7% of embryos have muscle defects in at least 2 hemisegments.
akirinEP906/Scer\GAL4pnr-MD237 is an enhancer of visible phenotype of pnrMD237
akirinEP906/Scer\GAL4pnr-MD237 is an enhancer of chaeta phenotype of pnrMD237
akirinEP906, twi1/twi[+] has larval somatic muscle cell phenotype
Bap60[+]/Bap601, akirinEP906 has larval somatic muscle cell phenotype
Scer\GAL4pnr-MD237, akirinEP906, pnrMD237 has scutellar bristle | increased number phenotype
Scer\GAL4pnr-MD237, akirinEP906, pnrMD237/pnr[+] has scutellar bristle | increased number phenotype
akirinEP906/+ results in disruption of the somatic muscle pattern when in double heterozygous combination with one of the following (% of stage 16 embryos with missing, misattached or duplicated muscles in at least 2 hemisegments is given in parentheses): twi1 (18.1%) or Bap601 (20.2%).
Separable from: a second unidentified lethal mutation on the chromosome.
Selected as: a P{EP} insertion line that modifies the pnrMD237/+ phenotype when expressed using Scer\GAL4pnr-MD237.